Keep Me Logged In
GW Pharmaceuticals' CEO Justin Gover says this successful clinical trial for new drug Epidiolex is not only good for the company but also for cannabinoids in modern medicine. CNBC's Meg Tirrell reports.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by